August's top stories: Novartis's MS drug investigation, Amgen buys Onyx
The US FDA is to investigate the brain infection of a patient receiving Novartis's MS drug and Amgen acquired US cancer drug producer Onyx Pharmaceuticals for $10.4bn, while EMA approves use of GSK's Tyverb with Herceptin. Pharmaceutical-technology.c…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Herceptin | Neurology | Pharmaceuticals